<?xml version='1.0' encoding='utf-8'?>
<document id="24831298"><sentence text="Possible interaction between letrozole and long-acting injectable zuclopenthixol."><entity charOffset="29-38" id="DDI-PubMed.24831298.s1.e0" text="letrozole" /><entity charOffset="66-80" id="DDI-PubMed.24831298.s1.e1" text="zuclopenthixol" /><pair ddi="false" e1="DDI-PubMed.24831298.s1.e0" e2="DDI-PubMed.24831298.s1.e0" /><pair ddi="false" e1="DDI-PubMed.24831298.s1.e0" e2="DDI-PubMed.24831298.s1.e1" /></sentence><sentence text="Mrs A, a 68-year-old woman with paranoid schizophrenia, was on long-term psychiatric treatment with long-acting intramuscular zuclopenthixol, quetiapine and alprazolam when, in April 2012, she was diagnosed with right breast infiltrating ductal carcinoma"><entity charOffset="126-140" id="DDI-PubMed.24831298.s2.e0" text="zuclopenthixol" /><entity charOffset="142-152" id="DDI-PubMed.24831298.s2.e1" text="quetiapine" /><entity charOffset="157-167" id="DDI-PubMed.24831298.s2.e2" text="alprazolam" /><pair ddi="false" e1="DDI-PubMed.24831298.s2.e0" e2="DDI-PubMed.24831298.s2.e0" /><pair ddi="false" e1="DDI-PubMed.24831298.s2.e0" e2="DDI-PubMed.24831298.s2.e1" /><pair ddi="false" e1="DDI-PubMed.24831298.s2.e0" e2="DDI-PubMed.24831298.s2.e2" /><pair ddi="false" e1="DDI-PubMed.24831298.s2.e1" e2="DDI-PubMed.24831298.s2.e1" /><pair ddi="false" e1="DDI-PubMed.24831298.s2.e1" e2="DDI-PubMed.24831298.s2.e2" /></sentence><sentence text=" After starting treatment with letrozole on 4 July, Mrs A progressively developed extrapyramidal symptoms and these were particularly evident after each zuclopenthixol administration"><entity charOffset="31-40" id="DDI-PubMed.24831298.s3.e0" text="letrozole" /><entity charOffset="153-167" id="DDI-PubMed.24831298.s3.e1" text="zuclopenthixol" /><pair ddi="false" e1="DDI-PubMed.24831298.s3.e0" e2="DDI-PubMed.24831298.s3.e0" /><pair ddi="false" e1="DDI-PubMed.24831298.s3.e0" e2="DDI-PubMed.24831298.s3.e1" /></sentence><sentence text=" On 9 January, both quetiapine and alprazolam were stopped due to excessive lethargy"><entity charOffset="20-30" id="DDI-PubMed.24831298.s4.e0" text="quetiapine" /><entity charOffset="35-45" id="DDI-PubMed.24831298.s4.e1" text="alprazolam" /><pair ddi="false" e1="DDI-PubMed.24831298.s4.e0" e2="DDI-PubMed.24831298.s4.e0" /><pair ddi="false" e1="DDI-PubMed.24831298.s4.e0" e2="DDI-PubMed.24831298.s4.e1" /></sentence><sentence text=" After the administration of the last dose of zuclopenthixol on 26 January, she presented with sedation, sialorrhea, festinant gait, axial dystonia and dysphagia, all of which were severe"><entity charOffset="46-60" id="DDI-PubMed.24831298.s5.e0" text="zuclopenthixol" /></sentence><sentence text=" The introduction of letrozole was the only change that had been made to her pharmacotherapeutic regimen in that period"><entity charOffset="21-30" id="DDI-PubMed.24831298.s6.e0" text="letrozole" /></sentence><sentence text=" The rest of the findings on neurological examination were normal" /><sentence text=" Renal function was adequate" /><sentence text=" Slow symptom onset and progressive worsening until full-blown clinical presentation after 6 months, and the dramatic improvement in the clinical picture achieved 2 days after treatment with biperiden, suggests a long-term insidious interaction leading to zuclopenthixol accumulation"><entity charOffset="256-270" id="DDI-PubMed.24831298.s9.e0" text="zuclopenthixol" /></sentence><sentence text=" To the best of our knowledge, this is the first report of a possible interaction between letrozole and zuclopenthixol"><entity charOffset="90-99" id="DDI-PubMed.24831298.s10.e0" text="letrozole" /><entity charOffset="104-118" id="DDI-PubMed.24831298.s10.e1" text="zuclopenthixol" /><pair ddi="false" e1="DDI-PubMed.24831298.s10.e0" e2="DDI-PubMed.24831298.s10.e0" /><pair ddi="false" e1="DDI-PubMed.24831298.s10.e0" e2="DDI-PubMed.24831298.s10.e1" /></sentence><sentence text=" We consider that it warrants further investigation" /><sentence text=" In the meanwhile, physicians should be aware of the occurrence of this potentially serious drug-drug interaction" /><sentence text="" /></document>